"Living with a question mark": psychosocial experience of Portuguese young adults at risk for hereditary amyloid transthyretin amyloidosis with polyneuropathy.

Amyloidosis, hereditary, transthyretin-related Genetic counseling Portugal Qualitative research Young adult

Journal

Journal of community genetics
ISSN: 1868-310X
Titre abrégé: J Community Genet
Pays: Germany
ID NLM: 101551501

Informations de publication

Date de publication:
08 Jul 2024
Historique:
received: 28 03 2024
accepted: 26 06 2024
medline: 8 7 2024
pubmed: 8 7 2024
entrez: 8 7 2024
Statut: aheadofprint

Résumé

This study is the first to explore the psychosocial experience of young Portuguese adults at genetic risk for hereditary amyloid transthyretin amyloidosis with polyneuropathy (hATTR-PN). The work focuses on the developmental peculiarities of their experience with the disease. Sixteen semi-structured interviews were conducted with young adults coming for pre-symptomatic testing (PST) at a single genetics outpatient center in Portugal. The data were analyzed qualitatively. The main findings suggest that four themes mark the psychosocial experience of the young adults interviewed. The first refers to the development of psychological representations, namely beliefs, mental representations, and social perceptions about hATTR-PN. The second regards the experienced and anticipated psychosocial impacts, namely, suffering, anxiety, and relief related to the disease. The third is related to using strategies such as performing PST, strategies focused on emotional regulation and the meaning of hATTR-PN, and social strategies to deal with these impacts over time. Finally, the fourth aspect concerns the perceived and expected support for the participants' needs provided by social contexts, that is, family and genetic counseling. In a period of life also marked by qualitatively different characteristics and developmental tasks from other life cycle stages (e.g., identity explorations, instability, and independent decision-making), experience with the disease can add psychosocial challenges to young adults at risk for hATTR-PN. Genetic counseling practices and health policies can be optimized to respond to the psychosocial needs of young adults. Future research should deepen the understanding of the psychosocial experience of individuals and families with late-onset hATTR-PN to improve the clinical response in this population.

Identifiants

pubmed: 38976223
doi: 10.1007/s12687-024-00717-8
pii: 10.1007/s12687-024-00717-8
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

© 2024. The Author(s).

Références

Adams D, Koike H, Slama M, Coelho T (2019) Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol 15:387–404. https://doi.org/10.1038/s41582-019-0210-4
doi: 10.1038/s41582-019-0210-4 pubmed: 31209302
Adams D, Ando Y, Beirão JM, Coelho T, Gertz MA, Gillmore JD, Hawkins PN, Lousada I, Suhr OB, Merlini G (2021) Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol 268:2109–2122. https://doi.org/10.1007/s00415-019-09688-0
doi: 10.1007/s00415-019-09688-0 pubmed: 31907599
Arnett JJ (2000) Emerging adulthood: a theory of development from the late teens through the twenties. Am Psychol 55:469–480. https://doi.org/10.1037/0003-066X.55.5.469
doi: 10.1037/0003-066X.55.5.469 pubmed: 10842426
Arnett JJ (2007) Emerging adulthood: what is it, and what is it good for? Child Dev Perspect 1:68–73. https://doi.org/10.1111/j.1750-8606.2007.00016.x
doi: 10.1111/j.1750-8606.2007.00016.x
Bulawa CE, Connelly S, Devit M, Wang L, Weigel C, Fleming JA, Packman J, Powers ET, Wiseman RL, Foss TR, Wilson IA, Kelly JW, Labaudinière R (2012) Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci USA 109:9629–9634. https://doi.org/10.1073/pnas.1121005109
doi: 10.1073/pnas.1121005109 pubmed: 22645360 pmcid: 3386102
Charmaz K (2006) Constructing grounded theory: a practical guide through qualitative analysis. SAGE, London
Creswell JW, Creswell JD (2018) Research design: qualitative, quantitative, and mixed methods approaches, 5th edn. SAGE, Los Angeles
Gibbs GR (2007) Analyzing qualitative data. SAGE, London
doi: 10.4135/9781849208574
González–Moreno J, Losada-López I, Cisneros-Barroso E, Garcia-Pavia P, González-Costello J, Muñoz-Beamud F, Campistol JM, Fernandez-Torron R, Chapman D, Amass L (2021) A descriptive analysis of ATTR amyloidosis in Spain from the transthyretin amyloidosis outcomes survey. Neurol Ther 10:833–845. https://doi.org/10.1007/s40120-021-00267-y
doi: 10.1007/s40120-021-00267-y pubmed: 34331265 pmcid: 8571440
Gorevic P, Franklin J, Chen J, Sajeev G, Wang JCH, Lin H (2021) Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy. Expert Opin Pharmacother 22:121–129. https://doi.org/10.1080/14656566.2020.1811850
doi: 10.1080/14656566.2020.1811850 pubmed: 32892660
Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN (1993) Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341:1113–1116. https://doi.org/10.1016/0140-6736(93)93127-m
doi: 10.1016/0140-6736(93)93127-m pubmed: 8097803
Inês M, Coelho T, Conceição I, Duarte-Ramos F, de Carvalho M, Costa J (2018) Epidemiology of transthyretin familial amyloid polyneuropathy in Portugal: a nationwide study. Neuroepidemiology 51:177–182. https://doi.org/10.1159/000490553
doi: 10.1159/000490553 pubmed: 30153683
Lêdo S, Paneque M, Rocha J, Leite Â, Sequeiros J (2013) Predictive testing for two neurodegenerative disorders (FAP and HD): a psychological point of view. Open J Genet 3:270–279. https://doi.org/10.4236/ojgen.2013.34030
doi: 10.4236/ojgen.2013.34030
Lêdo S, Ramires A, Leite Â, Dinis MAP, Sequeiros J (2018) Long-term predictors for psychological outcome of pre-symptomatic testing for late-onset neurological diseases. Eur J Med Genet 61:575–580. https://doi.org/10.1016/j.ejmg.2018.03.010
doi: 10.1016/j.ejmg.2018.03.010 pubmed: 29581083
Leite Â, Dinis MAP, Sequeiros J, Paúl C (2016) Subjects at-risk for genetic diseases in Portugal: illness representations. J Genet Counsel 25:79–89. https://doi.org/10.1007/s10897-015-9846-4
doi: 10.1007/s10897-015-9846-4
Leite Â, Dinis MAP, Sequeiros J, Paúl C (2017a) Motivation to perform presymptomatic testing in Portuguese subjects at-risk for late-onset genetic diseases. Interdisciplinaria 34:125–140. https://doi.org/10.16888/interd.2017.34.1.8
doi: 10.16888/interd.2017.34.1.8
Leite Â, Dinis MAP, Sequeiros J, Paúl C (2017b) Risk perception in subjects at-risk for familial amyloidotic polyneuropathy. Universitas Physiol 16:175–183. https://doi.org/10.11144/javeriana.upsy16-3.rpsf
doi: 10.11144/javeriana.upsy16-3.rpsf
Leite Â, Leite F, Dinis MAP (2017c) Subjects at risk for genetic late-onset neurological diseases: objective knowledge. Public Health Genomics 20:158–165. https://doi.org/10.1159/000479292
doi: 10.1159/000479292 pubmed: 28813711
Lopes A, Sousa A, Fonseca I, Branco M, Rodrigues C, Coelho T, Sequeiros J, Freitas P (2018b) Life paths of patients with transthyretin-related familial amyloid polyneuropathy Val30Met: a descriptive study. J Community Genet 9:93–99. https://doi.org/10.1007/s12687-017-0338-0
doi: 10.1007/s12687-017-0338-0 pubmed: 29052096
Lopes A, Rodrigues C, Fonseca I, Sousa A, Branco M, Coelho T, Sequeiros J, Freitas P (2018a) Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: does genetic risk affect family functioning? Clin Genet 94:401–408. https://doi.org/10.1111/cge.13416
doi: 10.1111/cge.13416 pubmed: 30019395
Magliano L, Obici L, Sforzini C, Mazzeo A, Russo M, Cappelli F, Fenu S, Luigetti M, Tagliapietra M, Gemelli C, Leonardi L, Tozza S, Pradotto LG, Citarelli G, Mauro A, Manganelli F, Antonini G, Grandis M, Fabrizi GM, Sabatelli M, Pareyson D, Perfetto F, Merlini G, Vita G, ATTRv C (2021) Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy. Orphanet J Rare Dis 16:163. https://doi.org/10.1186/s13023-021-01812-6
doi: 10.1186/s13023-021-01812-6 pubmed: 33827635 pmcid: 8028211
Matos C, Carvalho IP (2015) O impacto do gene - como vivenciam os portadores assintomáticos da paramiloidose a notícia do resultado do teste genético. Sinapse 15:5–12
Mendes Á, Sousa L, Sequeiros J, Clarke A (2017) Discredited legacy: stigma and familial amyloid polyneuropathy in Northwestern Portugal. Soc Sci Med 182:73–80. https://doi.org/10.1016/j.socscimed.2017.04.026
doi: 10.1016/j.socscimed.2017.04.026 pubmed: 28433926
Moos RH (ed) (1984) Coping with physical illness 2: new perspectives. Plenum, New York
Obici L, Kuks JB, Buades J, Adams D, Suhr OB, Coelho T, Kyriakides T, European Network for TTR-FAP (ATTReuNET) (2016) Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis. Curr Opin Neurol 29:S27–S35. https://doi.org/10.1097/WCO.0000000000000290
doi: 10.1097/WCO.0000000000000290 pubmed: 26734953 pmcid: 4739313
Oliveira CR, Mendes Á, Sousa L (2017a) From older to younger: intergenerational promotion of health behaviours in Portuguese families affected by familial amyloid polyneuropathy. Eur J Hum Genet 25:687–693. https://doi.org/10.1038/ejhg.2017.40
doi: 10.1038/ejhg.2017.40 pubmed: 28327574 pmcid: 5477368
Oliveira CR, Mendes Á, Sousa L (2017b) Promoção Da saúde em famílias com paramiloidose: papéis dos mais velhos junto dos mais novos. Cadernos De saúde pública 33:e00185515. https://doi.org/10.1590/0102-311X00185515
doi: 10.1590/0102-311X00185515 pubmed: 28614454
Oliveira CR, Mendes Á, Sousa L (2021) Impacto Dos papéis Dos mais velhos na promoção Da saúde em famílias com paramiloidose. PSICOLOGIA 35:17–26. https://doi.org/10.17575/psicologia.v35i2.1732
doi: 10.17575/psicologia.v35i2.1732
Paneque M, Félix J, Mendes Á, Lemos C, Lêdo S, Silva J, Sequeiros J (2019) Twenty years of a pre-symptomatic testing protocol for late-onset neurological diseases in Portugal. Acta Med Port 32:295–304. https://doi.org/10.20344/amp.10526
doi: 10.20344/amp.10526 pubmed: 31067424
Parman Y, Adams D, Obici L, Galán L, Guergueltcheva V, Suhr OB, Coelho T, European Network for TTR-FAP (ATTReuNET) (2016) Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol 29:S3–S13. https://doi.org/10.1097/WCO.0000000000000288
doi: 10.1097/WCO.0000000000000288 pubmed: 26734951 pmcid: 4739317
Rolim L, Leite Â, Lêdo S, Paneque M, Sequeiros J, Fleming M (2006) Psychological aspects of pre-symptomatic testing for Machado–Joseph disease and familial amyloid polyneuropathy type I. Clin Genet 69:297–305. https://doi.org/10.1111/j.1399-0004.2006.00606.x
doi: 10.1111/j.1399-0004.2006.00606.x pubmed: 16630162
Rolland JS (2012) Mastering family challenges in serious illness and disability. In: Walsh F (ed) Normal family processes: growing diversity and complexity, 4th edn. The Guilford Press, New York, pp 452–482
Rolland JS, Williams JK (2005) Toward a biopsychosocial model for 21st-century genetics. Fam Process 44:3–24. https://doi.org/10.1111/j.1545-5300.2005.00039.x
doi: 10.1111/j.1545-5300.2005.00039.x pubmed: 15807075
Schmidt HH, Waddington-Cruz M, Botteman MF, Carter JA, Chopra AS, Hopps M, Stewart M, Fallet S, Amass L (2018) Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve 57:829–837. https://doi.org/10.1002/mus.26034
doi: 10.1002/mus.26034 pubmed: 29211930 pmcid: 5947118
Sequeiros J (1996) Protocolo Geral do programa nacional de teste preditivo e aconselhamento genético na doença de Machado-Joseph. In: Sequeiros J (ed) O teste preditivo da doença de Machado-Joseph. UnIGENe, IBMC, Porto, pp 97–112
Tesch R (1990) Qualitative research: analysis types and software tools. Falmer, New York
Willoughby BJ, Augustus RA, Arnett JJ (2021) Communication during emerging adulthood. In: Vangelisti AL (ed) The Routledge handbook of family communication, 3rd edn. Routledge, London & New York, pp 262–276. https://doi.org/10.4324/9781003043423-23
doi: 10.4324/9781003043423-23

Auteurs

José D Pereira (JD)

CGPP - Centre for Predictive and Preventive Genetics, IBMC - Institute for Cell and Molecular Biology, University of Porto, Porto, Portugal. up201006364@edu.icbas.up.pt.
i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal. up201006364@edu.icbas.up.pt.
ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal. up201006364@edu.icbas.up.pt.

Catarina Costa (C)

CGPP - Centre for Predictive and Preventive Genetics, IBMC - Institute for Cell and Molecular Biology, University of Porto, Porto, Portugal.
i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
FMUP - Faculty of Medicine, University of Porto, Porto, Portugal.

Andreia Santos (A)

Associação de Solidariedade Social "O Tecto", Vila do Conde, Porto, Portugal.

Marina S Lemos (MS)

FPCEUP - Faculty of Psychology and Educational Sciences, University of Porto, Porto, Portugal.
CPUP - Center for Psychology, University of Porto, Porto, Portugal.

Jorge Sequeiros (J)

CGPP - Centre for Predictive and Preventive Genetics, IBMC - Institute for Cell and Molecular Biology, University of Porto, Porto, Portugal.
i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.

Milena Paneque (M)

CGPP - Centre for Predictive and Preventive Genetics, IBMC - Institute for Cell and Molecular Biology, University of Porto, Porto, Portugal.
i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.

Álvaro Mendes (Á)

CGPP - Centre for Predictive and Preventive Genetics, IBMC - Institute for Cell and Molecular Biology, University of Porto, Porto, Portugal.
i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.

Classifications MeSH